Switching warfarin patients to a direct oral anticoagulant during the Coronavirus Disease-19 pandemic

MeSH terms

• Administration, Oral
• Anticoagulants / adverse effects
• Anticoagulants / therapeutic use*
• COVID-19 / blood
• COVID-19 / complications*
• COVID-19 / epidemiology
• COVID-19 / prevention & control
• Counseling
• Drug Monitoring
• Drug Substitution / methods*
• Hospitals, University / organization & administration
• Hospitals, University / statistics & numerical data
• Humans
• Informed Consent
• London / epidemiology
• Pandemics*
• Patient Acceptance of Health Care
• Patient Education as Topic
• Pyridines / adverse effects
• Pyridines / therapeutic use*
• Quarantine
• Rivaroxaban / adverse effects
• Rivaroxaban / therapeutic use*
• SARS-CoV-2*
• Telemedicine
• Tertiary Care Centers / organization & administration
• Tertiary Care Centers / statistics & numerical data
• Thiazoles / adverse effects
• Thiazoles / therapeutic use*
• Thrombophilia / drug therapy*
• Thrombophilia / etiology
• Warfarin / therapeutic use*